• Home
  • Our Journey
    • About Us
    • Social Impact
    • About Damon Quisenberry
    • About AI System
  • Market Analysis
  • Investment Learning
    • American Equities
    • Capital Funds
    • Bond Securities
    • Currency Markets
    • Virtual Currencies
    • Worldwide Economics
    • Portfolio Strategies
    • Compliance Policies
  • Wealth Building
    • DZA Token
    • Strategy and Vision
    • Weekly Handpicked Stock Collection
  • Digital Learning
    • Learning archive
  • Online Event
    • Online Raffles
    • Voting Campaigns

Learning archive

Is Charter Communications (CHTR) Outperforming Other Consumer Discretionary Stocks This Year?
  • June 4, 2025

Is Charter Communications (CHTR) Outperforming Other Consumer Discretionary Stocks This Year?

Here is how Charter Communications (CHTR) and Legacy Education Inc. (LGCY) have performed compared to their sector so far this year.

Read More
Are Consumer Staples Stocks Lagging Ahold (ADRNY) This Year?
  • June 4, 2025

Are Consumer Staples Stocks Lagging Ahold (ADRNY) This Year?

Here is how Ahold NV (ADRNY) and Embotelladora Andina S.A. (AKO.B) have performed compared to their sector so far this year.

Read More
Why Popular (BPOP) is a Top Value Stock for the Long-Term
  • June 4, 2025

Why Popular (BPOP) is a Top Value Stock for the Long-Term

Wondering how to pick strong, market-beating stocks for your investment portfolio? Look no further than the Zacks Style Scores.

Read More
Axis Capital (AXS) is a Top-Ranked Value Stock: Should You Buy?
  • June 4, 2025

Axis Capital (AXS) is a Top-Ranked Value Stock: Should You Buy?

Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.

Read More
Angi (ANGI) Recently Broke Out Above the 20-Day Moving Average
  • June 4, 2025

Angi (ANGI) Recently Broke Out Above the 20-Day Moving Average

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

Read More
Brokers Suggest Investing in Lam Research (LRCX): Read This Before Placing a Bet
  • June 4, 2025

Brokers Suggest Investing in Lam Research (LRCX): Read This Before Placing a Bet

The average brokerage recommendation (ABR) for Lam Research (LRCX) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Read More
Is CrowdStrike (CRWD) a Buy as Wall Street Analysts Look Optimistic?
  • June 4, 2025

Is CrowdStrike (CRWD) a Buy as Wall Street Analysts Look Optimistic?

The average brokerage recommendation (ABR) for CrowdStrike (CRWD) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Read More
Should You Invest in SharkNinja, Inc. (SN) Based on Bullish Wall Street Views?
  • June 4, 2025

Should You Invest in SharkNinja, Inc. (SN) Based on Bullish Wall Street Views?

The average brokerage recommendation (ABR) for SharkNinja, Inc. (SN) is equivalent to a Buy. The overly optimistic recommendations of Wall Street analysts make the effectiveness of this highly sought-after metric questionable. So, is it worth buying the stock?

Read More
Wall Street Bulls Look Optimistic About Roblox (RBLX): Should You Buy?
  • June 4, 2025

Wall Street Bulls Look Optimistic About Roblox (RBLX): Should You Buy?

Based on the average brokerage recommendation (ABR), Roblox (RBLX) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Read More
Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?
  • June 4, 2025

Is It Worth Investing in Sensus Healthcare (SRTS) Based on Wall Street's Bullish Views?

Based on the average brokerage recommendation (ABR), Sensus Healthcare (SRTS) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Read More
  • ‹
  • 1
  • 2
  • ...
  • 87
  • 88
  • 89
  • 90
  • 91
  • 92
  • 93
  • ...
  • 1928
  • 1929
  • ›

Search

Recent Posts

  • An Exceptionally Rare Event for Stocks -- the 6th Occurrence in 35 Years -- Has Historically Led to Supercharged Returns for the S&P 500
    June 11, 2025
  • Private market push in focus as BlackRock hosts investor day
    June 11, 2025
  • Morning Bid: No relief from US-China trade truce
    June 11, 2025
  • DZ Alliance

    • [email protected]
      • Home
      • Our Journey
      • Market Analysis
      • Investment Learning
      • Wealth Building
      • Digital Learning
      • Online Event
    Copyright © 2025 DZ Alliance. All rights reserved.